Send me a link:

*Text messaging rates may apply.

 Dow Up 0.17% Nasdaq Up 0.44%

Revance Therapeutics, Inc. (RVNC)

-NasdaqGM
32.14 Up 0.65(2.06%) Jul 11, 4:00PM EDT
Prev Close:31.49
Open:31.35
Bid:26.00 x 200
Ask:34.00 x 200
1y Target Est:45.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:31.20 - 32.75
52wk Range:21.00 - 39.86
Volume:80,700
Avg Vol (3m):180,484
Market Cap:601.02M
P/E (ttm):N/A
EPS (ttm):-11.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RVNC

Comparison

Symbol% ChgMkt Cap
RVNCUp 2.06%601.02M
AGNUp 0.50%49.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):841.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.84
Quarterly EPS Est (Jun-14) :-0.68
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Revance Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic applications worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback